OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
PATAM55

Importadora y Exportadora de la Patagonia SA

Food Retail & DistributionVerified

The company maintains a relatively strong capital structure, with a debt-to-equity ratio of 0.18, indicating a low reliance on debt financing. However, its liquidity position is assessed as medium, with a current ratio of 1.47, suggesting that the company has sufficient short-term assets to cover its short-term liabilities, but not with a large margin of safety. The company's operating cash flow is negative at -32,570,703,000 ARS, which is a concern, but it is offset by a positive free cash flow of 26,252,164,000 ARS, indicating that the company is able to generate cash after capital expenditures. In terms of profitability, the company's return on equity is 5.44%, and its return on assets is 2.9%, which are metrics that should be compared to the industry median to determine relative performance. The company's gross profit of 710,389,982,000 ARS and operating income of 34,967,282,000 ARS suggest a healthy margin, but the net income of 31,535,010,000 ARS indicates that the company is managing to convert a portion of its operating income into net profit. The company's revenue is concentrated in the Food & Drug Retailing segment, and there is no specific information provided on geographic exposure or revenue concentration by region. The company's growth trajectory is not explicitly detailed, but the financial data suggests that the company is generating positive free cash flow, which could be indicative of a stable or growing business. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of concern is the negative net cash position after subtracting total debt, which could indicate potential liquidity challenges if not managed properly. There is no specific information provided on recent events such as filings or transcripts that would provide additional insight into the company's current situation.

30-day price · PATAM(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyImportadora y Exportadora de la Patagonia SA
TickerPATAM.BA
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Importadora y Exportadora de la Patagonia SA operates in the Food Retail & Distribution industry, generating revenue primarily through the retail and distribution of food and drug products.

Classification. The company is classified under the Consumer Non-Cyclicals economic sector, specifically in the Food & Drug Retailing business sector, with a high confidence level of 0.92.

The company maintains a relatively strong capital structure, with a debt-to-equity ratio of 0.18, indicating a low reliance on debt financing. However, its liquidity position is assessed as medium, with a current ratio of 1.47, suggesting that the company has sufficient short-term assets to cover its short-term liabilities, but not with a large margin of safety. The company's operating cash flow is negative at -32,570,703,000 ARS, which is a concern, but it is offset by a positive free cash flow of 26,252,164,000 ARS, indicating that the company is able to generate cash after capital expenditures. In terms of profitability, the company's return on equity is 5.44%, and its return on assets is 2.9%, which are metrics that should be compared to the industry median to determine relative performance. The company's gross profit of 710,389,982,000 ARS and operating income of 34,967,282,000 ARS suggest a healthy margin, but the net income of 31,535,010,000 ARS indicates that the company is managing to convert a portion of its operating income into net profit. The company's revenue is concentrated in the Food & Drug Retailing segment, and there is no specific information provided on geographic exposure or revenue concentration by region. The company's growth trajectory is not explicitly detailed, but the financial data suggests that the company is generating positive free cash flow, which could be indicative of a stable or growing business. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of concern is the negative net cash position after subtracting total debt, which could indicate potential liquidity challenges if not managed properly. There is no specific information provided on recent events such as filings or transcripts that would provide additional insight into the company's current situation.
Key takeaways
  • The company has a low debt-to-equity ratio, indicating a conservative capital structure.
  • The company's liquidity position is assessed as medium, with a current ratio of 1.47.
  • The company's operating cash flow is negative, but it is offset by a positive free cash flow.
  • The company's profitability metrics, such as return on equity and return on assets, should be compared to the industry median to determine relative performance.
  • The company's risk assessment indicates a medium liquidity risk and a low dilution risk.
  • # RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyARS
Revenue$2.55T
Gross profit$710.39B
Operating income$34.97B
Net income$31.54B
R&D
SG&A
D&A
SBC
Operating cash flow-$32.57B
CapEx-$40.00B
Free cash flow$26.25B
Total assets$1.09T
Total liabilities$505.74B
Total equity$579.99B
Cash & equivalents$18.98B
Long-term debt$104.20B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$579.99B
Net cash-$85.22B
Current ratio1.5
Debt/Equity0.2
ROA2.9%
ROE5.4%
Cash conversion-1.0%
CapEx/Revenue-1.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 184 companies
MetricPATAMActivity
Op margin1.4%3.1% medp25 1.2% · p75 6.8%below median
Net margin1.2%2.0% medp25 0.7% · p75 4.1%below median
Gross margin27.9%26.1% medp25 17.2% · p75 32.0%above median
CapEx / revenue-1.6%-2.5% medp25 -4.6% · p75 -1.4%above median
Debt / equity18.0%56.0% medp25 16.8% · p75 121.1%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-23 00:00 UTC#45d09c0b
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 22:19 UTCJob: 6aafe522